Regenxbio Vs. Sarepta Therapeutics Industry Stock Comparison

Sell

47

RGNX
Regenxbio

Last Price:

16.61

Seasonality Move:

3.1%

Buy

53

SRPT
Sarepta Therapeutics

Last Price:

132.54

Seasonality Move:

14.17%

Sell

47

Regenxbio (RGNX) is a Sell

Is Regenxbio a Buy, Sell or Hold?

The current Regenxbio [RGNX] share price is $16.67. The Score for RGNX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
RGNX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Buy

53

Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

The current Sarepta Therapeutics [SRPT] share price is $132.58. The Score for SRPT is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

RGNX Stock Price Chart

What is Regenxbio's stock price today?

The Regenxbio share price today is $16.67
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGNX is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

The Sarepta Therapeutics share price today is $132.58
The current trend is moderately bullish and SRPT is experiencing slight selling pressure.

RGNX Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.7	Sell
Relative Strength Index (14 RSI):	42.2	Sell
Chaikin Money Flow:	-57891	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(15.86 - 18.4)	Sell
Bollinger Bands (100):	(14.78 - 20.92)	Sell

SRPT Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	2.66	Buy
Relative Strength Index (14 RSI):	60.93	Buy
Chaikin Money Flow:	-291001	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(119.26 - 131.36)	Buy
Bollinger Bands (100):	(108.01 - 132.53)	Buy

RGNX Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	16.44	Buy
20-day SMA:	16.65	Buy
50-day SMA:	19.48	Sell
200-day SMA:	17.71	Sell
8-day EMA:	16.61	Buy
20-day EMA:	17.04	Sell
50-day EMA:	17.97	Sell
200-day EMA:	18.4	Sell

SRPT Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	131.76	Buy
20-day SMA:	125.07	Buy
50-day SMA:	125.52	Buy
200-day SMA:	112.6	Buy
8-day EMA:	131.64	Buy
20-day EMA:	128.08	Buy
50-day EMA:	125.22	Buy
200-day EMA:	117.23	Buy

Regenxbio Earnings Growth & RGNX Earnings Dates

Analysts estimate an earnings increase this quarter of $0.35 per share, an increase next quarter of $0.05 per share, an increase this year of $1.00 per share, and an increase next year of $2.51 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

Analysts estimate an earnings increase this quarter of $1.85 per share, an increase next quarter of $1.52 per share, an increase this year of $5.62 per share, and an increase next year of $6.11 per share.

Regenxbio Technical Analysis

	Apr 25	Apr 26	Apr 29	Apr 30	May 1	May 2	May 3	May 6	May 7	May 8
	Apr					May
	25	26	29	30	01	02	03	06	07	08
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

	Apr 25	Apr 26	Apr 29	Apr 30	May 1	May 2	May 3	May 6	May 7	May 8
	Apr					May
	25	26	29	30	01	02	03	06	07	08
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):